14 results on '"Man SF"'
Search Results
2. DNA methylation is associated with airflow obstruction in patients living with HIV
- Author
-
Hernandez Cordero, Ana I, primary, Yang, Chen Xi, additional, Obeidat, Maen, additional, Yang, Julia, additional, MacIsaac, Julie, additional, McEwen, Lisa, additional, Lin, David, additional, Kobor, Michael, additional, Novak, Richard, additional, Hudson, Fleur, additional, Klinker, Hartwig, additional, Dharan, Nila, additional, Man, SF Paul, additional, Sin, Don D, additional, Kunisaki, Ken, additional, and Leung, Janice, additional
- Published
- 2020
- Full Text
- View/download PDF
3. DNA methylation is associated with airflow obstruction in patients living with HIV.
- Author
-
Cordero, Ana I. Hernandez, Chen Xi Yang, Obeidat, Maen, Yang, Julia, MacIsaac, Julie, McEwen, Lisa, Lin, David, Kobor, Michael, Novak, Richard, Hudson, Fleur, Klinker, Hartwig, Dharan, Nila, Man, S. F. Paul, Sin, Don D., Kunisaki, Ken, Leung, Janice, Hernandez Cordero, Ana I, Yang, Chen Xi, Man, Sf Paul, and INSIGHT START Pulmonary and Genomic Substudy Groups
- Subjects
DNA methylation ,EPIGENOMICS ,HEPATITIS B ,HIGHLY active antiretroviral therapy ,TRP channels ,HIV-positive persons ,HIV infections ,RESEARCH ,RESEARCH methodology ,MEDICAL cooperation ,EVALUATION research ,COMPARATIVE studies ,OBSTRUCTIVE lung diseases ,PULMONARY function tests ,RESEARCH funding - Abstract
Introduction: People living with HIV (PLWH) suffer from age-related comorbidities such as COPD. The processes responsible for reduced lung function in PLWH are largely unknown. We performed an epigenome-wide association study to investigate whether blood DNA methylation is associated with impaired lung function in PLWH.Methods: Using blood DNA methylation profiles from 161 PLWH, we tested the effect of methylation on FEV1, FEV1/FVC ratio and FEV1 decline over a median of 5 years. We evaluated the global methylation of PLWH with airflow obstruction by testing the differential methylation of transposable elements Alu and LINE-1, a well-described marker of epigenetic ageing.Results: Airflow obstruction as defined by a FEV1/FVC<0.70 was associated with 1393 differentially methylated positions (DMPs), while 4676 were associated with airflow obstruction based on the FEV1/FVCConclusion: A large number of DMPs were associated with airflow obstruction and lung function in a unique cohort of PLWH. Airflow obstruction in even relatively young PLWH is associated with global hypomethylation, suggesting advanced epigenetic ageing compared with those with normal lung function. The disturbance of the epigenetic regulation of key genes not previously identified in non-HIV COPD cohorts could explain the unique risk of COPD in PLWH. [ABSTRACT FROM AUTHOR] - Published
- 2021
- Full Text
- View/download PDF
4. DNA methylation is associated with airflow obstruction in patients living with HIV
- Author
-
Hernandez Cordero, Ana I, Yang, Chen Xi, Obeidat, Maen, Yang, Julia, MacIsaac, Julie, McEwen, Lisa, Lin, David, Kobor, Michael, Novak, Richard, Hudson, Fleur, Klinker, Hartwig, Dharan, Nila, Man, SF Paul, Sin, Don D, Kunisaki, Ken, and Leung, Janice
- Abstract
IntroductionPeople living with HIV (PLWH) suffer from age-related comorbidities such as COPD. The processes responsible for reduced lung function in PLWH are largely unknown. We performed an epigenome-wide association study to investigate whether blood DNA methylation is associated with impaired lung function in PLWH.MethodsUsing blood DNA methylation profiles from 161 PLWH, we tested the effect of methylation on FEV1, FEV1/FVC ratio and FEV1decline over a median of 5 years. We evaluated the global methylation of PLWH with airflow obstruction by testing the differential methylation of transposable elements Alu and LINE-1, a well-described marker of epigenetic ageing.ResultsAirflow obstruction as defined by a FEV1/FVC<0.70 was associated with 1393 differentially methylated positions (DMPs), while 4676 were associated with airflow obstruction based on the FEV1/FVC
- Published
- 2021
- Full Text
- View/download PDF
5. The relationship betweenHelicobacter pyloriseropositivity and COPD
- Author
-
Sze, Marc A, primary, Chen, Yu-Wei Roy, additional, Tam, Sheena, additional, Tashkin, Donald, additional, Wise, Robert A, additional, Connett, John E, additional, Man, SF Paul, additional, and Sin, Don D, additional
- Published
- 2015
- Full Text
- View/download PDF
6. Discovery of novel plasma protein biomarkers to predict imminent cystic fibrosis pulmonary exacerbations using multiple reaction monitoring mass spectrometry.
- Author
-
Quon BS, Dai DL, Hollander Z, Ng RT, Tebbutt SJ, Man SF, Wilcox PG, and Sin DD
- Subjects
- Adult, Disease Progression, Female, Follow-Up Studies, Humans, Male, Retrospective Studies, Time Factors, Biomarkers blood, Blood Proteins analysis, Cystic Fibrosis blood, Mass Spectrometry methods, Monitoring, Physiologic methods, Proteomics methods
- Abstract
Background: Despite the significant morbidity and mortality related to pulmonary exacerbations in cystic fibrosis (CF), there remains no reliable predictor of imminent exacerbation., Objective: To identify blood-based biomarkers to predict imminent (<4 months from stable blood draw) CF pulmonary exacerbations using targeted proteomics., Methods: 104 subjects provided plasma samples when clinically stable and were randomly split into discovery (n=70) and replication (n=34) cohorts. Multiple reaction monitoring mass spectrometry (MRM-MS) was used to measure 117 peptides (79 proteins) from plasma. Plasma proteins with differential abundance between subjects who did versus did not develop an imminent exacerbation were analysed and proteins with fold difference >1.5 between the groups were included in an MRM-MS classifier model to predict imminent exacerbations. Performance characteristics were compared with clinical predictors and candidate plasma protein biomarkers., Results: Six proteins were included in the final MRM-MS protein panel. The area under the curve (AUC) for the prediction of imminent exacerbations was highest for the MRM-MS protein panel (AUC 0.74) in comparison to FEV1% predicted (AUC 0.55) and the top candidate plasma protein biomarkers, including C-reactive protein (AUC 0.61) and interleukin-6 (AUC 0.60). The MRM-MS protein panel performed similarly in the replication cohort (AUC 0.73)., Conclusions: Using MRM-MS, a six-protein panel measured from plasma can distinguish individuals with versus without an imminent exacerbation. With further replication and assay development, this biomarker panel may be clinically applicable for prediction of exacerbations in individuals with CF., (Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/)
- Published
- 2016
- Full Text
- View/download PDF
7. CT in COPD: just a pretty picture or really worth a thousand words (or dollars)?
- Author
-
Sin DD, Leipsic J, and Man SF
- Subjects
- Humans, Male, Forced Expiratory Volume physiology, Pulmonary Emphysema diagnostic imaging, Respiratory Insufficiency diagnostic imaging, Smoking adverse effects, Tomography, X-Ray Computed
- Published
- 2011
- Full Text
- View/download PDF
8. Associations of IL6 polymorphisms with lung function decline and COPD.
- Author
-
He JQ, Foreman MG, Shumansky K, Zhang X, Akhabir L, Sin DD, Man SF, DeMeo DL, Litonjua AA, Silverman EK, Connett JE, Anthonisen NR, Wise RA, Paré PD, and Sandford AJ
- Subjects
- Case-Control Studies, Female, Forced Expiratory Volume, Haplotypes, Humans, Interleukin-6 blood, Linkage Disequilibrium, Male, Middle Aged, Phenotype, Pulmonary Disease, Chronic Obstructive physiopathology, Interleukin-6 genetics, Polymorphism, Single Nucleotide, Pulmonary Disease, Chronic Obstructive genetics
- Abstract
Background: Interleukin-6 (IL6) is a pleiotropic pro-inflammatory and immunomodulatory cytokine which probably plays an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). There is a functional single nucleotide polymorphism (SNP), -174G/C, in the promoter region of IL6. It was hypothesised that IL6 SNPs influence susceptibility for impaired lung function and COPD in smokers., Methods: Seven and five SNPs in IL6 were genotyped in two nested case-control samples derived from the Lung Health Study (LHS) based on phenotypes of rate of decline of forced expiratory volume in 1 s (FEV(1)) over 5 years and baseline FEV(1) at the beginning of the LHS. Serum IL6 concentrations were measured for all subjects. A partially overlapping panel of nine IL6 SNPs was genotyped in 389 cases of COPD from the National Emphysema Treatment Trial (NETT) and 420 controls from the Normative Aging Study (NAS)., Results: In the LHS, three IL6 SNPs were associated with decline in FEV(1) (0.023< or =p< or =0.041 in additive models). Among them, the IL6_-174C allele was associated with a rapid decline in lung function. The association was more significant in a genotype-based analysis (p = 0.006). In the NETT-NAS study, IL6_-174G/C and four other IL6 SNPs, all of which are in linkage disequilibrium with IL6_-174G/C, were associated with susceptibility to COPD (0.01< or =p< or =0.04 in additive genetic models)., Conclusion: The results suggest that the IL6_-174G/C SNP is associated with a rapid decline in FEV(1) and susceptibility to COPD in smokers.
- Published
- 2009
- Full Text
- View/download PDF
9. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease.
- Author
-
Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, and Sin DD
- Subjects
- Adult, Cardiovascular Diseases blood, Cardiovascular Diseases mortality, Cause of Death, Female, Forced Expiratory Volume physiology, Humans, Male, Middle Aged, Pulmonary Disease, Chronic Obstructive blood, Pulmonary Disease, Chronic Obstructive physiopathology, Risk Factors, C-Reactive Protein metabolism, Pulmonary Disease, Chronic Obstructive mortality
- Abstract
Background: Although C-reactive protein (CRP) levels are increased in chronic obstructive pulmonary disease (COPD), it is not certain whether they are associated with adverse clinical outcomes., Methods: Serum CRP levels were measured in 4803 participants in the Lung Health Study with mild to moderate COPD. The risk of all-cause and disease specific causes of mortality was determined as well as cardiovascular event rates, adjusting for important covariates such as age, sex, cigarette smoking, and lung function. Cardiovascular events were defined as death from coronary heart disease or stroke, or non-fatal myocardial infarction or stroke requiring admission to hospital., Results: CRP levels were associated with all-cause, cardiovascular, and cancer specific causes of mortality. Individuals in the highest quintile of CRP had a relative risk (RR) for all-cause mortality of 1.79 (95% confidence interval (CI) 1.25 to 2.56) compared with those in the lowest quintile of CRP. For cardiovascular events and cancer deaths the corresponding RRs were 1.51 (95% CI 1.20 to 1.90) and 1.85 (95% CI 1.10 to 3.13), respectively. CRP levels were also associated with an accelerated decline in forced expiratory volume in 1 second (p < 0.001). The discriminative property of CRP was greatest during the first year of measurement and decayed over time. Comparing the highest and lowest CRP quintiles, the RR was 4.03 (95% CI 1.23 to 13.21) for 1 year mortality, 3.30 (95% CI 1.38 to 7.86) for 2 year mortality, and 1.82 (95% CI 1.22 to 2.68) for > or =5 year mortality., Conclusions: CRP measurements provide incremental prognostic information beyond that achieved by traditional markers of prognosis in patients with mild to moderate COPD, and may enable more accurate detection of patients at a high risk of mortality.
- Published
- 2006
- Full Text
- View/download PDF
10. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link?
- Author
-
Sin DD and Man SF
- Subjects
- C-Reactive Protein metabolism, Forced Expiratory Volume physiology, Humans, Interleukin-6 metabolism, Exercise Tolerance physiology, Inflammation physiopathology, Muscle Weakness physiopathology, Muscle, Skeletal physiopathology, Pulmonary Disease, Chronic Obstructive physiopathology
- Published
- 2006
- Full Text
- View/download PDF
11. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis.
- Author
-
Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, and Sin DD
- Subjects
- Female, Forced Expiratory Volume physiology, Humans, Lung Neoplasms physiopathology, Male, Prospective Studies, Risk Factors, Sex Factors, Lung Neoplasms etiology
- Abstract
Background: Individuals with severely impaired lung function have an increased risk of lung cancer. Whether milder reductions in forced expiratory volume in 1 second (FEV(1)) also increase the risk of lung cancer is controversial. Moreover, there is little consensus on whether men and women have similar risks for lung cancer for similar decreases in FEV(1)., Methods: A search was conducted of PubMed and EMBASE from January 1966 to January 2005 and studies that examined the relationship between FEV1 and lung cancer were identified. The search was limited to studies that were population based, employed a prospective design, were large in size (> or = 5000 participants), and adjusted for cigarette smoking status., Results: Twenty eight abstracts were identified, six of which did not report FEV1 and eight did not adjust for smoking. Included in this report are four studies that reported FEV1 in quintiles. The risk of lung cancer increased with decreasing FEV1. Compared with the highest quintile of FEV1 (> 100% of predicted), the lowest quintile of FEV1 (< approximately 70% of predicted) was associated with a 2.23 fold (95% confidence interval (CI) 1.73 to 2.86) increase in the risk for lung cancer in men and a 3.97 fold increase in women (95% CI 1.93 to 8.25). Even relatively small decrements in FEV1 ( approximately 90% of predicted) increased the risk for lung cancer by 30% in men (95% CI 1.05 to 1.62) and 2.64 fold in women (95% CI 1.30 to 5.31)., Conclusion: Reduced FEV1 is strongly associated with lung cancer. Even a relatively modest reduction in FEV1 is a significant predictor of lung cancer, especially among women.
- Published
- 2005
- Full Text
- View/download PDF
12. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
- Author
-
Jayaram L, Pizzichini E, Lemière C, Man SF, Cartier A, Hargreave FE, and Pizzichini MM
- Subjects
- Acetates adverse effects, Adult, Androstadienes adverse effects, Anti-Asthmatic Agents adverse effects, Cyclopropanes, Double-Blind Method, Eosinophils drug effects, Female, Fluticasone, Humans, Leukotriene Antagonists adverse effects, Male, Patient Compliance, Quinolines adverse effects, Sputum cytology, Sulfides, Treatment Outcome, Acetates administration & dosage, Androstadienes administration & dosage, Anti-Asthmatic Agents administration & dosage, Asthma drug therapy, Leukotriene Antagonists administration & dosage, Pulmonary Eosinophilia drug therapy, Quinolines administration & dosage
- Abstract
Background: Inhaled corticosteroids and leukotriene receptor antagonists reduce airway eosinophilia and have been used as first line anti-inflammatory therapy for mild persistent asthma., Methods: A multicentre, randomised, placebo controlled, parallel group study was performed to compare the anti-inflammatory effects of fluticasone propionate and montelukast as measured by sputum eosinophils in 50 adults with symptomatic steroid naive asthma and sputum eosinophilia of > or =3.5%., Results: Eighteen patients received low dose fluticasone (250 mug/day), 19 received montelukast (10 mg/day), and 13 were given placebo for 8 weeks. Fluticasone treatment resulted in a greater reduction in sputum eosinophils (geometric mean (SD) 11.9 (2.3)% to 1.7 (5.1)%) than montelukast (10.7 (2.3)% to 6.9 (3.8)%; p = 0.04) or placebo (15.4 (2.4)% to 7.8 (4.2)%; p = 0.002), and improvement in FEV(1) (mean (SD) 2.6 (0.9) l to 3.0 (0.9) l) than montelukast (2.8 (0.7) l to 2.8 (0.9) l; p = 0.02) or placebo (2.4 (0.8) l to 2.4 (0.9) l; p = 0.01). Treatment with fluticasone suppressed sputum eosinophilia within a week while montelukast only attenuated it. The effect of montelukast was maximal at 1 week and was maintained over 4 weeks. The effect of fluticasone was maintained over 8 weeks while that of montelukast was not., Conclusions: Montelukast is not as effective as low dose fluticasone in reducing or maintaining an anti-inflammatory effect in steroid naive eosinophilic asthma.
- Published
- 2005
- Full Text
- View/download PDF
13. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.
- Author
-
Gan WQ, Man SF, Senthilselvan A, and Sin DD
- Subjects
- C-Reactive Protein analysis, Cytokines blood, Fibrinogen analysis, Forced Expiratory Volume physiology, Humans, Inflammation blood, Leukocytes, Pulmonary Disease, Chronic Obstructive blood, Vital Capacity physiology, Inflammation complications, Pulmonary Disease, Chronic Obstructive etiology
- Abstract
Background: Individuals with chronic obstructive pulmonary disease (COPD) are at increased risk of cardiovascular diseases, osteoporosis, and muscle wasting. Systemic inflammation may be involved in the pathogenesis of these disorders. A study was undertaken to determine whether systemic inflammation is present in stable COPD., Methods: A systematic review was conducted of studies which reported on the relationship between COPD, forced expiratory volume in 1 second (FEV(1)) or forced vital capacity (FVC), and levels of various systemic inflammatory markers: C-reactive protein (CRP), fibrinogen, leucocytes, tumour necrosis factor-alpha (TNF-alpha), and interleukins 6 and 8. Where possible the results were pooled together to produce a summary estimate using a random or fixed effects model., Results: Fourteen original studies were identified. Overall, the standardised mean difference in the CRP level between COPD and control subjects was 0.53 units (95% confidence interval (CI) 0.34 to 0.72). The standardised mean difference in the fibrinogen level was 0.47 units (95% CI 0.29 to 0.65). Circulating leucocytes were also higher in COPD than in control subjects (standardised mean difference 0.44 units (95% CI 0.20 to 0.67)), as were serum TNF-alpha levels (standardised mean difference 0.59 units (95% CI 0.29 to 0.89))., Conclusions: Reduced lung function is associated with increased levels of systemic inflammatory markers which may have important pathophysiological and therapeutic implications for subjects with stable COPD.
- Published
- 2004
- Full Text
- View/download PDF
14. Impaired lung function and serum leptin in men and women with normal body weight: a population based study.
- Author
-
Sin DD and Man SF
- Subjects
- Adult, Age Distribution, Aged, Body Mass Index, Body Weight, Cardiovascular Diseases blood, Cohort Studies, Cross-Sectional Studies, Female, Forced Expiratory Volume physiology, Humans, Lung Diseases physiopathology, Male, Middle Aged, Multivariate Analysis, Risk Factors, Vital Capacity physiology, Cardiovascular Diseases etiology, Leptin blood, Lung Diseases blood
- Abstract
Background: Impaired lung function is a risk factor for cardiovascular morbidity. Whether circulating factors are responsible for this association is unknown. A study was undertaken to determine whether leptin, a hormone that can promote atherothrombosis, is raised in individuals with impaired lung function., Methods: Data from non-obese participants in the Third National Health, Nutrition, and Examination Survey (n=2808) were analysed to determine the relationship between circulating leptin levels and forced expiratory volume in 1 second (FEV(1)) values divided into quintiles (quintile 1, FEV(1) predicted < or =85.2%; quintile 2, 85.3-94.3%; quintile 3, 94.4-101.4%; quintile 4, 101.5-110.0%; and quintile 5, > or =110.1%)., Results: Serum leptin levels changed along the FEV(1) gradient. The highest leptin levels were found in quintile 1 (geometric mean (GM) 5.42; interquartile range (IQR) 3.00-9.60 fg/l) and the lowest in quintile 5 (GM 4.94; IQR 2.80-9.10 fg/l). Adjustments for age, body mass index, and other confounders strengthened this relationship. Compared with quintile 5, the odds of having an increased serum leptin level in quintiles 1, 2, 3, and 4 were 2.26 (95% confidence interval (CI) 1.54 to 3.31), 2.20 (95% CI 1.52 to 3.17), 1.46 (95% CI 1.01 to 2.09), and 1.28 (95% CI 0.90 to 1.83), respectively., Conclusion: Individuals with impaired lung function have raised serum leptin levels. Leptin may play a role in the pathogenesis of cardiovascular morbidity and mortality related to impaired lung function.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.